Azitra (AZTR) Revenue (2022 - 2024)
Azitra's (AZTR) quarterly Revenue came in at $7500.0 in Q2 2024, down 95.64% YoY from $172000.0 in Q3 2023, and down 91.67% on a QoQ basis from $90000.0 in Q4 2023.
Azitra (AZTR) Revenue (2022 - 2024) Analysis & Trends
Azitra (AZTR) has 3 years of Revenue data on file, last reported at $7500.0 in Q2 2024.
- Quarterly Revenue fell 95.64% year-over-year to $7500.0 in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $7500.0 (down 98.16% YoY) and the FY2024 annual result came in at $7500.0, down 98.91% from the prior year.
- Revenue eased to $7500.0 in Q2 2024, from $90000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $310700.0 in Q3 2023 to a low of $7500.0 in Q2 2024.
- A 3-year average of $107187.5 and a median of $87500.0 in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue surged 540.62% — and 2024, when it slumped 95.64%.
- Tracing AZTR's Revenue over 3 years: stood at $30500.0 in 2022, then soared by 195.08% to $90000.0 in 2023, then sank by 91.67% to $7500.0 in 2024.
- The last three Revenue figures came in at $7500.0 (Q2 2024), $90000.0 (Q4 2023), and $310700.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Azitra | 2.44 Mn | 2.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 7,500.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 310,700.00 |
| Jun 30, 2023 | 172,000.00 |
| Mar 31, 2023 | 113,300.00 |
| Dec 31, 2022 | 30,500.00 |
| Sep 30, 2022 | 48,500.00 |
| Jun 30, 2022 | 85,000.00 |